Evaluation of the Antibody Persistence Beyond Five Years After Immunization With MenFiveTM (NmCV-5), a Pentavalent Meningococcal ACYWX Conjugate Vaccine

by | Jan 30, 2026 | Clinical Trials | 0 comments

​ Conditions: Meningoccocal Disease

Sponsors: Serum Institute of India Pvt. Ltd.

Not yet recruiting Conditions: Meningoccocal Disease
Sponsors: Serum Institute of India Pvt. Ltd.
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *